Related Experiment Videos
Role of splenectomy in hematologic disorders
1Department of Surgery, University of Rochester, School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York 14642, USA.
World Journal of Surgery
|November 1, 1996
Summary
Splenectomy is increasingly used for hematologic diseases like hereditary spherocytosis and idiopathic thrombocytopenic purpura. Careful preoperative management and vaccination are crucial to prevent overwhelming postsplenectomy sepsis.
Area of Science:
- Hematology
- Surgical Oncology
Background:
- Indications for splenectomy in hematologic diseases are expanding.
- Splenectomy offers curative or therapeutic benefits for various blood disorders.
Purpose of the Study:
- To review the expanding indications for splenectomy in hematologic conditions.
- To highlight key considerations for splenectomy, including preoperative management and potential complications.
Main Methods:
- Review of current medical literature on splenectomy for hematologic diseases.
- Analysis of specific indications, patient management, and postoperative outcomes.
Main Results:
- Hereditary spherocytosis and idiopathic thrombocytopenic purpura (ITP) are primary indications.
- Splenectomy is also beneficial for acquired hemolytic anemias, other thrombocytopenias, and myeloproliferative disorders.
- Palliative splenectomy may aid chemotherapy in chronic leukemias and lymphomas.
Conclusions:
- Splenectomy is a valuable treatment for numerous hematologic disorders.
- Preoperative vaccination against pneumococcal and Hemophilus influenzae is essential.
- Awareness and management of overwhelming postsplenectomy sepsis are critical for patient safety.